Dr Reddy's acquires Italy's Jet Generici for undisclosed sum
MUMBAI (Thomson Financial) - Dr Reddy's Laboratories Ltd. said it has acquired Jet Generici Srl, a company which sells generic finished dosages in Italy, for an undisclosed amount, through its Italian subsidiary, Reddy Pharma Italia SpA.
In a regulatory filing, the Indian pharmaceutical company said the acquisition will help in establishing the company's generic business in Italy and also provide access to an essential product portfolio, a pipeline of registration applications and a sales and marketing organisation.
Dr Reddy's shares provisionally closed 2.75 percent lower at 619.15 rupees on the Bombay Stock Exchange, while the benchmark Sensex provisionally closed 0.55 percent higher at 15,836.60.
In a regulatory filing, the Indian pharmaceutical company said the acquisition will help in establishing the company's generic business in Italy and also provide access to an essential product portfolio, a pipeline of registration applications and a sales and marketing organisation.
Dr Reddy's shares provisionally closed 2.75 percent lower at 619.15 rupees on the Bombay Stock Exchange, while the benchmark Sensex provisionally closed 0.55 percent higher at 15,836.60.
0 comments:
Post a Comment